Everbright

Everbright is China’s cross-border investment and asset management company.

Business Model:

Revenue: $0

Employees: 201-500

Rankings

Industries / Tags:

Detailed Everbright Information

Geographic Data

Everbright headquarters map

Address:

City: Wan Chai

State: Hong Kong Island

Zip:

Country: Hong Kong

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

3,169,084Website Global Rank

5,099Website Monthly Traffic

Twitter Followers

Description

China Everbright Limited (“Everbright”, stock code: 165.HK) was established at Hong Kong in 1997, Everbright persistently pursues its “Macro Asset Management” strategy, with specific focuses on cross-border asset management and investment business. Over the past years, Everbright manages series of private equity funds, venture capital funds, sector focus funds, mezzanine funds, hedge funds and principal investment as operated via an international management platform, and provides overseas investors with opportunities to explore and invest in companies with fast growing potential in Mainland China. On the other hand, Everbright also seeks investment opportunities from overseas and provides diversified financial services for its clients in Mainland China. China Everbright Limited, being a member of China Everbright Group, is the second largest shareholder of Everbright Securities (stock code: 601788.SH), a strategic shareholder of China Everbright Bank (stock code: 601818.SH, 6818.HK), the controlling shareholder of the Hong Kong-listed China Aircraft Leasing Group Holdings Limited (stock code: 1848.HK) and the second largest shareholder of the Singapore-listed Ying Li International Real Estate Limited(stock code:5DM. SGX). After the launch of "Shanghai-Hong Kong Stock Connect" on 10 April 2014, Everbright becomes one of the first batch of specific stocks listed on The Stock Exchange of Hong Kong which can be directly traded by Mainland investors. Through upholding the philosophy of “Making Wealth Simple”, Everbright leverages on its own substantial financial strength, as well as the position and influence of China Everbright Group and its affiliated companies in the financial industry in China, and has successfully built huge cross-border social and business networks in Hong Kong and the Mainland, and established a reputable image in the market.

Contact Phone:

Contact Email:

Everbright went public on 12/3/1992 on the SSE

Listed Exchange:
SSE

IPO Date:
12/3/1992

Ticker Symbol:
600622

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
8/2019 Terminus Technologies Series C 0
6/2017 Dt Dream Series A 110M
2/2019 Nreal Series A 16M
11/2017 SICHUAN TE QU EDUCATION MANAGEMENT Co., Ltd Angel Round 453.7k
5/2018 Lifetech Scientific Co, Ltd Post-IPO Equity -
2/2011 TaiRui Series A 1.5M
5/2018 DiYiDan Series C 4.7M
1/2010 iSoftStone Series C -
8/2016 Ambrx Venture Round 0
11/2018 NetEase Cloud Music Series B 600M
3/2019 Googut Wine &a; Spirits Venture Round 149M
9/2018 Yijiupi Series D 200M
10/2021 Jiuduuoduo Series A 16M
8/2019 Gary &a; Bros Series A -
4/2020 T11 Food Market Series A 0
11/2020 Hedonova Series A 0
10/2018 T11 Food Market Angel Round 0
5/2016 Terminus Technologies Series A -
7/2017 Terminus Technologies Series A 73.5M
6/2014 ReSound Series A 6M
4/2017 Mylio Venture Round 25M
7/2015 SINOWEL Series C 4.8M
11/2016 Miaopai Series E 500M
9/2016 Shanghai Film Art Academy Venture Round -
1/2017 ESR Private Equity Round 0
4/2019 InDeco China Series B -
4/2019 Tongdun Technology Series D 100M
10/2018 Terminus Technologies Series B 172.7M
11/2007 lijiababy Angel Round 404.7k
6/2018 Mevion Medical Systems Private Equity Round 150M
11/2019 Juvenile Get Series A 0
4/2020 Yeelight Series C 0
3/2013 Knowgene Series A 1.6M
8/2011 ReSound Angel Round 4.6M
12/2020 WT Microtech Medical Series D 0
9/2021 IASO Biotherapeutics Series C 0
9/2021 Reforgene Medicine Series A -
2/2018 lijiababy Series C 4.7M
4/2018 Arctic Green Energy Venture Round 150M
11/2013 Amcare Women&s;s and Children&s;s Hospital Private Equity Round 100M
3/2022 Grit Science Series A 0
3/2022 Grit Science Series A 0
10/2021 Jiuduuoduo Series A 0
9/2021 IASO Biotherapeutics Series C 0
9/2021 Reforgene Medicine Series A -
12/2020 WT Microtech Medical Series D 0
11/2020 Hedonova Series A 0
4/2020 T11 Food Market Series A 0
4/2020 Yeelight Series C 0
11/2019 Juvenile Get Series A 0
8/2019 Terminus Technologies Series C 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Announced Date Transaction Number of Investors Money Raised Lead Investors

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research